Conceptus (CPTS) Files Patent Infringement Suit Against Hologic (HOLX)
Conceptus, Inc. (Nasdaq: CPTS) announced that it filed a lawsuit in the United States District Court, Northern District of California against Hologic, Inc., (Nasdaq: HOLX) seeking a declaration by the Court that Hologic's planned importation, use, sale or offer to sell of its forthcoming Adiana Permanent Contraception system, will infringe several U.S. patents owned by Conceptus, including U.S. Patent Nos. 6,634,361, 6,709,667, 7,237,552, 7,428,904 and 7,506,650. Conceptus seeks an injunction prohibiting Hologic from importing, using, selling or offering to sell its Adiana system in the United States.
Conceptus, Inc. develops, manufactures and markets the Essure permanent birth control system, a medical device for women that is approved for marketing in the United States by the United States Food and Drug Administration (FDA). [SM]
Conceptus, Inc. develops, manufactures and markets the Essure permanent birth control system, a medical device for women that is approved for marketing in the United States by the United States Food and Drug Administration (FDA). [SM]
You May Also Be Interested In
- DISH Network (DISH) Sued by Networks for 'Commercial Skipping' Feature
- Heritage Oaks Bancorp (HEOP) pays deferred interest on TARP preferreds
- United Technologies (UTX) Prices Aggregate $9.8B Senior Notes Offering
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
